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Abstract 
Endothelial cells release various substances to control the tone of the underlying 
vascular smooth muscle. Nitric oxide (NO) is the best defined endothelium-derived 
relaxing factor (EDRF). Endothelial cells can also increase vascular tone by releasing 
endothelium-derived contracting factors (EDCF). The over-production of EDCF 
contributes to the endothelial dysfunctions which accompanies various vascular 
diseases. The present review summarizes and discusses the mechanisms leading to the 
release of EDCFs derived from the metabolism of arachidonic acid. This release can 
be triggered by agonists such as acetylcholine, adenosine nucleotides or by stretch. All 
these stimuli are able to induce calcium influx into the endothelial cells, an effect 
which can be mimicked by calcium ionophores. The augmentation in intracellular 
calcium ion concentration initiates the release of EDCF. Downstream processes 
include activation of phospholipase A2 (PLA2), cyclooxygenases (COX) and the 
production of reactive oxygen species (ROS) and vasoconstrictor prostanoids 
(endoperoxides, prostacyclin, thromboxane A2 and other prostaglandins) which 
subsequently diffuse to, and activate thromboxane-prostanoid (TP) receptors on the 
vascular smooth muscle cells leading to contraction. 
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Introduction 
Following the first report by Furchgott and Zawadzki (1980) that in response to 
acetylcholine, endothelial cells release a vasodilator substance [endothelium-derived 
relaxing factor (EDRF)] later identified as nitric oxide (NO), a number of other 
inhibitory endothelial signals [endothelium-derived hyperpolarizing factors (EDHF)] 
have been shown to contribute to relaxations of the underlying vascular smooth 
muscle cells (Furchgott and Vanhoutte, 1989; Luescher and Vanhoutte, 1990; 
Vanhoutte, 1993; Gluais et al., 2005a; Gluais et al., 2005b; Feletou and Vanhoutte, 
2006; Shi et al., 2006; Michel et al., 2008).  In addition, it soon became apparent that 
under certain circumstances the endothelium can also produce diffusible substances 
[endothelium-derived contracting factors (EDCF)] which activate the contractile 
process in the underlying vascular smooth muscle cells (De Mey and Vanhoutte, 
1982). Besides receptors-mediated agonists such as thrombin, acetylcholine and 
adenosine nucleotides (ADP and ATP) (Luescher and Vanhoutte, 1986; Katusic et al., 
1988; Mombouli and Vanhoutte, 1993), stretch can also elicit endothelium-dependent 
contractions, at least in canine cerebral arteries (Katusic et al., 1987). The early 
observation that such endothelium-dependent contractions could be prevented by 
inhibitors of cyclooxygenase suggested that down-stream products of this enzyme, i.e. 
prostanoids, were likely candidates as EDCF (Miller and Vanhoutte, 1985; Luescher 
and Vanhoutte, 1986; Auch-Schwelk et al., 1989; Yang et al., 2002; Yang et al., 
2003a). Although endothelial cells can produce vasoconstrictors including 
endothelin-1 and angiotensin II, there is lack of convincing evidence showing a direct 
link between these substances and instantaneous changes in tension that can be 
attributed to the release of EDCF. Thus, the present article focuses on the mechanisms 
leading to the production of endothelial and cyclooxygenase-derived vasoconstrictors, 
and updates earlier reviews on this topic (Feletou et al., 2009; Shi and Vanhoutte, 
2009; Tang and Vanhoutte, 2009). 
 
Endothelial calcium concentration 
An increase in intracellular calcium concentration in the endothelial cells is the 
triggering event leading to the release of EDCF. This conclusion is based on the 
following observations: (a) Activation of cell membrane receptors by agonists such as 
acetylcholine [activating endothelial M3-muscarinic receptors (Boulanger et al., 
1994)], ADP and ATP [activating purinoceptors (Koga et al., 1989; Mombouli and 
Vanhoutte, 1993)], which are known to induce the release of calcium from the 
sarcoplasmic reticulum (Liu et al., 2009), initiate the production of EDCF; (b) 
Reduction in the extracellular calcium concentration decreases 
endothelium-dependent contractions (Okon et al., 2002); (c) Calcium ionophores such 
as A23187 elicit endothelium-dependent contractions (Katusic et al., 1988; Gluais et 
al., 2006; Shi et al., 2007a; Tang et al., 2007; Wong et al., 2008); (d) 
Endothelium-dependent contractions induced by acetylcholine in the rat aorta are 
accompanied by an increase in cytosolic endothelial calcium concentration (Tang et 
al., 2007; Wong et al., 2008) and this increment is greater in preparations of 
spontaneously hypertensive rats (SHR) compared to those of age-matched 
normotensive Wistar-Kyoto rats (WKY), in line with the larger EDCF-mediated 
responses in the former (Luescher and Vanhoutte, 1986; Yang et al., 2003a; Tang et al., 
2007). On the other hand, no significant difference in the increase of calcium 
concentration in the two strains was observed if the aortae were exposed to A23187 
(Tang et al., 2007). 
 
Phospholipase A2
The increase in endothelial concentration of the activator ion elicited by agonists such 
as acetylcholine involves two steps, release of calcium from the sarcoplasmic 
reticulum followed by influx of extracellular calcium. Acetylcholine binds to the G 
proteins-coupled muscarinic receptors on the endothelial cell membrane and activates 
phospholipase C. The latter produces inositol triphosphate which in turn causes the 
release of calcium from intracellular stores. The resulting calcium-depletion process 
leads to the production of a messenger termed calcium influx factor [CIF; 
(Randriamampita and Tsien, 1993)] which displaces the inhibitory calmodulin from 
the calcium-independent phospholipase A2 [iPLA2; (Wolf and Gross, 1996; Wolf et al., 
1997; Trepakova et al., 2000; Smani et al., 2004)]. Activation of iPLA2 is an initiating 
event in the generation of EDCF induced by acetylcholine in the rat aorta (Wong et al., 
2010). Activated iPLA2 produces lysophospholipids which facilitate the opening of 
store-operated calcium channels (SOCs) leading to the influx of extracellular calcium 
into the endothelial cells (Trepakova et al., 2001; Smani et al., 2004). This large influx 
of calcium ions then activates the calcium-dependent phospholipase A2 (cPLA2) 
which converts membrane phospholipids to arachidonic acids, the precursor of 
prostanoids (Figure 1). That the calcium-dependent form of phospholipase A2 is 
crucial for the ultimate production of EDCF is demonstrated by the observation that a 
specific inhibitor of iPLA2 does not affect A23187-induced endothelium-dependent 
contractions, while quinacrine, which inhibits both forms of the enzyme, abolishes the 
response to both acetylcholine and A23187 (Luescher and Vanhoutte, 1986; Wong et al., 
2010). 
 Vitamin D and EDCF 
High concentrations of vitamin D appear to have an acute protective effect on 
endothelial cells by reducing the production of EDCF. Indeed, the in vitro 
administration of 1,25-dihydroxyvitamin D3 [the most active metabolite of vitamin D 
(Holick, 2003)] reduces EDCF-mediated responses induced by acetylcholine but not 
by the calcium ionophore A23187 in aorta of both SHR and WKY (Wong et al., 
2008), suggesting that vitamin D acutely reduces EDCF production by an action 
upstream of the increase in calcium concentration and thus interferes with the calcium 
surging process (Figure 1) (Wong et al., 2008). 
 
Cyclooxygenase 
The two isoforms of cyclooxygenase (COX), COX-1 and COX-2, have a comparable 
ability to catalyze the transformation of arachidonic acid into prostaglandins  
(Figure 2) (Garavito and DeWitt, 1999). Both isoforms can play a key role in the 
generation of EDCF depending on the species, the blood vessel studied and the health 
conditions of the donor (Furchgott and Vanhoutte, 1989; Luescher and Vanhoutte, 
1990; Kauser and Rubanyi, 1995; Shi et al., 2007a; Tang and Vanhoutte, 2009; 
Vanhoutte, 2009; Vanhoutte et al., 2009; Wong et al., 2009). COX-1 is constitutively 
expressed in most tissues while COX-2 is inducible (Vane et al., 1998; Davidge, 
2001). Early studies demonstrated that non-selective COX inhibitors abolish 
endothelium-dependent contractions (Miller and Vanhoutte, 1985; Katusic et al., 
1988), an observation that has been repeated over the years. Selective inhibitors of 
COX-1, but not those of COX-2, abrogate endothelium-dependent contractions in the 
rat aorta (Ge et al., 1995; Ospina et al., 2003; Yang et al., 2003a; Yang et al., 2004a). 
In that preparation, COX-1 is expressed in both endothelial and vascular smooth 
muscle cells, but the over-expression of this isoform seen in the SHR aorta is confined 
to the endothelial cells (Tang and Vanhoutte, 2008b). Likewise, bioassay studies 
demonstrate that only the activation of endothelial COX contributes to the generation 
of diffusible EDCF in the SHR aorta (Yang et al., 2003a). Endothelium-dependent 
contractions are present in the aorta of COX-2, but not in that of COX-1 knock-out 
mice (Tang et al., 2005b). Taken in conjunction, these findings demonstrated that 
COX-1 is the preferential constitutive isoform of cyclooxygenase which mediates 
endothelium-dependent contractions in large arteries of rat and mice. However, with 
aging or disease, COX-2 can be induced and then contributes to EDCF-mediated 
responses (Camacho et al., 1998; Blanco-Rivero et al., 2005; Shi et al., 2008; 
Matsumoto et al., 2009). By contrast, constitutively expressed COX-2 plays a 
dominant role in the endothelium-dependent contraction of the hamster aorta 
irrespective of age (Wong et al., 2009). 
 
Prostanoids 
Cyclooxygenase converts arachidonic acid into endoperoxides (PGH2), the 
intermediate of the prostanoid biosynthesis, which can either act as an EDCF per se 
(Asano et al., 1994; Ge et al., 1995) or be further transformed into prostacyclin (PGI2), 
thromboxane A2 and various other prostaglandins including prostaglandin D2 (PGD2), 
prostaglandin E2 (PGE2) and prostaglandin F2α (PGF2α) by their respective synthases 
(Figure 2) (Gluais et al., 2005c; Gluais et al., 2006; Gluais et al., 2007; Tang and 
Vanhoutte, 2008b).  
Although PGH2 has a relatively short half-life and is unstable (Auch-Schwelk et al., 
1990), it can be a vasoconstrictor EDCF (Ge et al., 1995; Gluais et al., 2006; Gluais et 
al., 2007; Tang and Vanhoutte, 2008b) by activating TP receptors of vascular smooth 
muscle (Auch-Schwelk et al., 1990; Ito et al., 1991; Ge et al., 1995). This conclusion 
is supported by two observations: (a) The aorta of SHR releases more PGH2 than that 
of WKY when exposed to acetylcholine (Ge et al., 1995). (b) Similarly to the 
acetylcholine-induced EDCF-mediated responses, PGH2-induced contractions in 
aortae without endothelium are transient and are larger in SHR compared to WKY 
(Ge et al., 1995; Gluais et al., 2005c). In addition, when tyrosine nitration caused by 
the local production of peroxynitrite inhibits the activity of prostacyclin synthase (Zou 
et al., 2002), PGH2 may become even more important in the process. 
Prostacyclin is the major cyclooxygenase-derived metabolite of arachidonic acid in 
endothelial cells (Moncada et al., 1976). During endothelium-dependent contractions 
of rodent aortae in response to acetylcholine, its production is markedly larger than 
that of other prostaglandins and, together with PGH2, prostacyclin becomes a major 
EDCF (Ge et al., 1995; Blanco-Rivero et al., 2005; Gluais et al., 2005c; Feletou et al., 
2009; Tang and Vanhoutte, 2009). This conclusion is in line with the findings that the 
gene expression of PGI synthase in the rat aortic endothelial cells is greatly 
augmented by aging and spontaneous hypertension (Tang and Vanhoutte, 2008b). 
During ADP- and A23187-induced endothelium-dependent contractions, the release 
of thromboxane A2 is augmented and an inhibitor of thromboxane A2 can reduce these 
contractions, unlike those to acetylcholine (Auch-Schwelk et al., 1990; Gluais et al., 
2006; Gluais et al., 2007). Therefore, thromboxane A2 can be regarded as a key EDCF 
during the EDCF-mediated responses elicited by these agents. Likewise, in certain 
blood vessels (hamster aorta) or with aging and disease (such as diabetes), an 
augmented contribution of PGE2 and PGF2α to EDCF-mediated contractions may 
become obvious (Matsumoto et al., 2009a; Wong et al., 2009). This can be explained 
best by the increased generation of these prostaglandins under conditions of enhanced 
oxidative stress (Gryglewski et al., 1986), in particular as a consequence of the 
augmented formation of peroxynitrite which inhibits PGI synthase (Zou et al., 1999; 
Zou et al., 2002) and diverts arachidonic acid towards PGE2 and PGF2α synthases 
(Gluais et al., 2005). Obviously, the involvement of individual prostanoids in 
EDCF-mediated responses varies depending on the species, the blood vessels studied, 
the endothelium-dependent agonist used, and the age and disease state of the donor. 
 
Reactive oxygen species 
Reactive oxygen species (ROS) are generated during a number of normal metabolic 
activities, but their overproduction leads to oxidative stress which is commonly 
observed in hypertension, diabetes and atherosclerosis (Liu et al., 2005; Shi et al., 
2007b; Shi and Vanhoutte, 2009). During the generation of prostanoids by COX, ROS 
are formed as by-products. ROS of relevance for endothelium-dependent responses 
include superoxide anions (O2-), hydroxyl radicals (．OH) and hydrogen peroxide 
(H2O2) (Figure 3). ROS either directly act as EDCF (Katusic and Vanhoutte, 1989; 
Katusic et al., 1993) or indirectly potentiate EDCF-mediated responses by reducing 
the bioavailability of NO (Rubanyi and Vanhoutte, 1986; Huie and Padmaja, 1993; 
Paolocci et al., 2001) and activating COX in the vascular smooth muscle cells 
(Auch-Schwelk et al., 1989; Hibino et al., 1999; Yang et al., 2002). This conclusion is 
based on the following observations: (a) An increased ROS production accompanies 
acetylcholine- or A23187-induced endothelium-dependent contractions (Tang et al., 
2007); (b) Tiron (which scavenges superoxide anions intracellularly) or catalase 
(which converts hydrogen peroxide to water and oxygen) plus deferoxamine (which 
prevents the formation of hydroxyl radicals) reduce endothelium-dependent 
contractions in the SHR aorta (Yang et al., 2003b) and the femoral artery of diabetic 
rats (Shi et al., 2007b), suggesting that superoxide anions and hydrogen peroxide 
augment or even mediate part of the response; (c) ROS formed by the xanthine plus 
xanthine oxidase reaction elicit contractions of SHR aortae without endothelium 
which are prevented by both COX inhibitors and TP receptor antagonists, suggesting 
that the oxygen-derived free radicals stimulate COX in the vascular smooth muscle to 
produce prostanoids which in turn activate their TP receptors (Auch-Schwelk et al., 
1989; Yang et al., 2003b). (d) ROS increase the degradation of nitric oxide (Rubanyi 
and Vanhoutte, 1986; Paolocci et al., 2001); (d) Peroxynitrite, a strong cytosolic 
oxidant generated by the reaction of the superoxide anions and nitric oxide, inactivate 
PGI synthase (Zou et al., 1999; Zou et al., 2002) and shifts the production of 
prostacyclin to that of other vasoconstrictor prostanoids (Cohen, 2002; Gluais et al., 
2005). (e) In canine basilar arteries, superoxide dismutase (SOD) plus catalase abolish 
the A23187 induced endothelium-dependent contractions but not the production of 
prostaglandins and thromboxane A2 indicating that ROS rather than COX-derived 
prostanoids are the EDCF in this particular artery (Katusic and Vanhoutte, 1989); (f) 
In the rat pulmonary artery, ROS induce contraction involving the activity of protein 
kinase C in the vascular smooth muscle (Jin et al., 1991); (g) In vascular smooth 
muscle of the rat aorta, the ROS-induced calcium sensitization is mediated through the 
activation of Rho and a subsequent increase in Rho kinase activity (Jin et al., 2004), 
and the latter is crucial in the response to EDCF (Chan et al., 2009); and (h) ROS 
directly depolarize vascular smooth muscle by inhibiting ATP-sensitive potassium 
channel (KATP), voltage-activated potassium channel (Kv) and large conductance 
calcium-activated potassium channel (BKCa) (Kinoshita et al., 2004; Li et al., 2004; 
Tang et al., 2004). 
 
Gap junctions 
The contact between endothelial and vascular smooth muscle cells is important in the 
genesis of endothelium-dependent contractions. This conclusion is supported by the 
observation that the endothelium-dependent contractile response to acetylcholine of 
layered bioassay (“sandwich”) preparations of SHR aortae is much smaller than that 
of intact aortic rings (Yang et al., 2003b). The contraction in the “sandwich 
preparation” is caused by prostanoids which diffuse across the intracellular gap 
between the donor (containing endothelial cells) and the recipient strip (without 
endothelium, responsible for the contraction). Under bioassay conditions, superoxide 
dismutase plus catalase (both compounds with poor cell permeability) can reduce the 
acetylcholine-induced endothelium-dependent contractions while they have no effect 
in intact rings in which tiron inhibits EDCF-mediated responses (Auch-Schwelk et al., 
1989; Yang et al., 2003a). These observations imply that in intact rings, ROS exert 
their facilitatory effect by either acting in the endothelial cells or being transported 
from the latter to the vascular smooth muscle cells via preferential channels not 
accessible to superoxide dismutase. One possible route would be the myoendothelial 
gap junctions (Figure 4), since the gap junction inhibitor carbenoxolone reduces 
endothelium-dependent contractions to acetylcholine and the calcium ionophore 
A23187 (Tang and Vanhoutte, 2008a). 
 
Prostanoid receptors and Rho kinase 
Thromboxane-prostanoid receptors (TP-receptors) are the most important prostanoid 
receptor subtype involved in endothelium-dependent contractions since TP receptor 
antagonists abolish these responses (Auch-Schwelk et al., 1990; Kato et al., 1990; 
Yang et al., 2003a). All prostanoids can bindto and activate TP receptors, albeit with 
different affinities (Dickinson and Murphy, 2002). Thromboxane A2 is the most potent 
agonist at TP receptors. Endoperoxides and prostacyclin also activate TP receptors 
and both of them evoke transient contractions (probably due to their short half-life) 
which mimic acetylcholine-induced endothelium-dependent contractions (Gluais et al., 
2005). Binding of EDCF to the TP receptors in turn activates the downstream Rho 
kinase pathway leading to the increased contractile activity of the vascular smooth 
muscle (Chan et al., 2009). 
In the SHR aorta, the gene expression levels and protein presence of TP receptors are 
not altered, but the responsiveness to endoperoxides is augmented compared to WKY 
preparations (Ge et al., 1995; Tang and Vanhoutte, 2008b). This hyperresponsiveness 
contributes to the prominence of EDCF-mediated responses in the aorta of the SHR. 
Another crucial aspect in this prominence is that the vascular smooth muscle of aging 
WKY and of the SHR have lost the ability to respond with relaxation to prostacyclin, 
despite an unchanged expression of IP receptors and the large production of 
prostacyclin by endothelial cells exposed to acetycholine or A23187 (Levy, 1980; 
Rapoport and Williams, 1996; Gluais et al., 2005; Tang and Vanhoutte, 2008b) 
 
Interactions between NO, EDHF and EDCF 
In the SHR aorta, the concomitant release of NO inhibits endothelium-dependent 
contractions to acetylcholine (Auch-Schwelk et al., 1992; Yang et al., 2004b), an 
observation that has lead to the systematic use of inhibitors of NO synthases when 
studying EDCF-mediated responses. In addition, previous exposure to 
endothelium-derived NO or exogenous NO-donors causes a long-term inhibition of 
EDCF-mediated responses (Tang et al., 2005a; Feletou et al., 2008). Likewise, in the 
renal artery of the rat, the absence of EDHF favours the occurrence of 
endothelium-dependent contractions (Michel et al., 2008). 
Alternatively, EDCF may also counteract the action of endothelium-derived relaxing 
factors. Thus, in WKY mesenteric artery, EDHF-mediated relaxations are attenuated 
by the release of EDCF (Sekiguchi et al., 2002). This attenuation is explained best by 
the EDCF-induced activation of TP-receptors which depolarizes the vascular smooth 




In the early nineteenth century, Bayliss showed that an increase in the internal 
pressure in the carotid artery of the dog caused its constriction, a seminal observation 
leading to the concept of autoregulation (Bayliss, 1902). In isolated basilar arteries of 
the same species, stretch induces a contraction which disappears after the removal of 
the endothelium, demonstrating an endothelium-dependent process (Katusic et al., 
1987). This contraction is sensitive to both the COX inhibitor indomethacin and the 
calcium-influx blocker diltiazem, suggesting that the activity of COX (presumably in 
the endothelial cells) and the influx of extracellular calcium (presumably in the 
vascular smooth muscle cells) are required for the active response to stretch (Katusic 
et al., 1987). Likewise, in bovine coronary arteries, stretch elicits an 
endothelium-independent contraction which requires the activation of NAD(P)H 
oxidase (Oeckler et al., 2003). Stretch also directly activates various cation channels 
on the smooth muscle cells of small arteries facilitating their contraction (Setoguchi et 
al., 1997; Hill et al., 2001; Wu and Davis, 2001). Oxygen-derived free radicals play a 
key role in endothelium-dependent contractions of the canine basilar artery (Katusic 
and Vanhoutte, 1989). Thus, it is tempting to speculate that the 
endothelium-dependent contraction evoked by stretch (resulting from activation of 
endothelial COX, the production of ROS and the hypersensitivity of the vascular 
smooth muscle) may initiate the autoregulatory response, at least in cerebral arteries. 
 
Pathophysiological relevance 
As mentioned already, endothelium-dependent contractions are exacerbated by aging, 
diabetes, hypertension and atherosclerosis (Taddei et al., 2006; Vanhoutte and Tang, 
2008; Vanhoutte et al., 2009). Foe example, the blunted endothelium-dependent 
relaxations in response to acetylcholine in diabetic animals is partly due to the 
augmented production of EDCF, resulting from the over-expression and activation of 
COX and increased ROS production after the chronic exposure of the endothelial cells 
to high glucose levels (De Vriese et al., 2000). In essential hypertensive patients, the 
blunted vasodilatation induced by acetylcholine can almost be normalized by the 
COX inhibitor indomethacin indicating that COX-derived vasoconstrictors are key 
players responsible for the abnormal endothelial response (Taddei et al., 1998). This 
indomethacin-sensitive impairment of the response to acetylcholine is accentuated by 
aging (Taddei et al., 2006). However, in secondary hypertension, inhibition of COX 
does not restore the acetylcholine-induced vasodilatation suggesting that EDCFs are 
not equally important in all cases of hypertension. It is likely that the prominence of 
endothelium-dependent contractions observed in arteries of aging and diseased 
(essential hypertension, diabetes) animals and human reflects the progressive inability 
of the endothelial cells to generate enough NO to curtail the production of EDCF 
(Tang et al., 2005a; Feletou et al., 2008; Vanhoutte et al., 2009). Shifting from the 
normal release of NO (and EDHF) to that of EDCF likely plays an important role in 
the development of vascular disease (Vanhoutte, 1997; Vanhoutte et al., 2009).
 
Conclusion 
Endothelial cells release COX-derived vasoconstrictor prostanoids and reactive 
oxygen species, which have been termed EDCF. In the SHR, prostacyclin becomes a 
prominent EDCF acting on TP-receptors, even more so that IP receptor signaling is 
impaired (Rapoport and Williams, 1996; Gluais et al., 2005; Feletou et al., 2009). 
EDCF-mediated responses are amplified in aging normotensive animals (Koga et al., 
1989; Wong et al., 2009), hypertensive (Luescher and Vanhoutte, 1986) and diabetic 
(Tesfamariam et al., 1989; Shi et al., 2007b; Shi et al., 2008; Shi and Vanhoutte, 2009) 
animals. In humans, EDCF plays a role in the endothelial dysfunction that 
accompanies aging, atherosclerosis, myocardial infarction and essential hypertension 
(Boulanger, 1999; Vita and Keaney, 2002; Taddei et al., 2006). 
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Figure 1 Acetylcholine (ACh) activates muscarinic receptors (M) on the endothelial 
cell membrane and triggers the release of calcium from intracellular stores. The 
resulting calcium-depletion process displaces the inhibitory calmodulin (CaM) from 
iPLA2. Activated iPLA2 produces lysophospholipids (LysoPL) which in turn open 
store-operated calcium channels (SOCs) leading to the influx of extracellular calcium 
into the endothelial cells. This large influx of calcium ions then activates cPLA2 
which catalyze the production of arachidonic acids (AA). The later is then 
metabolized by cyclooxygenase-1 (COX-1) to prostanoids. 1,25-Dihydroxyvitamin 
D3 (Vit D) acutely reduces endothelium-dependent contraction by inhibiting the 
calcium surge. cPLA2 = calcium dependent phospholipase A2; EC = endothelial cells; 
iPLA2 = calcium independent phospholipase A2; PGD2= prostaglandin D2; PGE2 = 
prostaglandin E2; PGF2α = prostaglandin F2α; PGH2 = endoperoxides; PGI2 = 
prostacyclin; PL = phospholipids; SERCA = sarco/endoplasmic reticulum 
Ca2+-ATPase; SR = sarcoplasmic reticulum; TXA2 = thromoboxane A2.
Figure 2 Metabolism of arachidonic acid and its downstream metabolites. 
Arachidonic acid is converted to endoperoxides by the activity of cyclooxygenases 
(COX).  Endoperoxides are then converted to various prostaglandins by their 
respective synthase. Michael: I added Cox-1 & 2; can you fit that into the usual 
endothelial cells?
Figure 3 Formation of oxygen-derived free radicals of relevance for 
endothelium-dependent responses, and pharmacological agents commonly used to 
determine their importance. Superoxide anions (O2−) can be generated from molecular 
oxygen by the actions of various enzymes. O2− can react with NO to form 
peroxynitrite (ONOO−). It can also be converted to hydrogen peroxide (H2O2) by 
superoxide dismutase (SOD). H2O2 can be transformed to hydroxyl radicals by 
ferrous ions or converted to H2O by catalase and glutathione. Tiron scavenges O2− 
inside cells. DETCA inhibits SOD. Deferoxamine is an iron chelator that scavenges 
hydroxyl radicals. L-NAME inhibits NO synthase. MnTMPyP mimics the combined 
effect of SOD and catalase. DETCA = diethyldithiocarbamic acid; GSH = glutathione; 
GSSG = glutathione disulphide; L-NAME = Nω-nitro-L-arginine methyl ester 
hydrochloride; MnTMPyP = Mn(III)tetrakis(1-methyl-4-pyridyl)porphyrin 
pentachloride; NO = nitric oxide; tiron = 4,5-dihydroxy-1,3-benzenedisulphonic acid. 
( Aapted from Shi et al. 2007, by permission).
Figure 4 Endothelium-dependent contraction comprises of two components: 
endoperoxides (and their downstream metabolites) and ROS. Both components 
require an increase in endothelial calcium concentration, the activity of endothelial 
COX and the stimulation of the TP receptors to elicit contraction. Prostanoids diffuse 
from the endothelial cell to the vascular smooth muscle cell while ROS utilize both 
diffusion and possibly myoendothelial gap junctions. AA = arachidonic acid; ACh = 
acetylcholine; COX-1 = cyclooxygenase-1; H2O2 = hydrogen peroxide; m = 
muscarinic receptors; p = purinergic receptors; PGD2= prostaglandin D2; PGE2 = 
prostaglandin E2; PGF2α = prostaglandin F2α; PGI2 = prostacyclin; PGIS = 
prostacyclin synthase; PLA2 = phospholipase A2; ROS = reactive oxygen species; TP 
= thromboxane-prostanoid receptors; TXA2 = thromboxane A2; TXAS = 
thromboxane synthase. X = xanthine; XO = xanthine oxidase. Michael: please ask 
Eva for the exact reference! 
 
